BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1397742)

  • 1. The potential clinical role of intravenous omeprazole.
    Brunner GH; Thiesemann C
    Digestion; 1992; 51 Suppl 1():17-20. PubMed ID: 1397742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage].
    Artal A; Lanas A; Barrao ME; Moliner FJ; Blas JM; López J
    Rev Esp Enferm Dig; 1996 Mar; 88(3):191-6. PubMed ID: 8645512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL; Banner W
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
    Kiilerich S; Rannem T; Elsborg L
    Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
    Lanas A; Artal A; Blás JM; Arroyo MT; Lopez-Zaborras J; Sáinz R
    J Clin Gastroenterol; 1995 Sep; 21(2):103-6. PubMed ID: 8583073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
    Labenz J; Peitz U; Leusing C; Tillenburg B; Blum AL; Börsch G
    Gut; 1997 Jan; 40(1):36-41. PubMed ID: 9155573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intravenous omeprazole on non-variceal upper gastrointestinal bleeding after endoscopic treatment: a comparative study.
    Këlliçi I; Kraja B; Mone I; Prifti S
    Med Arh; 2010; 64(6):324-7. PubMed ID: 21218747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
    Cardi M; Muttillo IA; Amadori L; Barillari P; Sammartino P; Arnone F; Signorelli C; Bolognese A
    Ann Chir; 1997; 51(2):136-9. PubMed ID: 9297869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
    Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
    N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH.
    Laterre PF; Horsmans Y
    Crit Care Med; 2001 Oct; 29(10):1931-5. PubMed ID: 11588454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
    N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 0.5 mg/kg versus 1 mg/kg of intravenous omeprazole for the prophylaxis of gastrointestinal bleeding in critically ill children: a randomized study.
    Solana MJ; López-Herce J; Sánchez A; Sánchez C; Urbano J; López D; Carrillo A
    J Pediatr; 2013 Apr; 162(4):776-782.e1. PubMed ID: 23149178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
    Villanueva C; Balanzó J; Torras X; Sáinz S; Soriano G; González D; Vilardell F
    Endoscopy; 1995 May; 27(4):308-12. PubMed ID: 7555936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial.
    Brunner G; Chang J
    Digestion; 1990; 45(4):217-25. PubMed ID: 2205527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous omeprazole after endoscopic treatment of bleeding peptic ulcers.
    Palmer KR
    Gut; 2001 Nov; 49(5):610-1. PubMed ID: 11600458
    [No Abstract]   [Full Text] [Related]  

  • 18. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
    Merki HS; Wilder-Smith CH
    Gastroenterology; 1994 Jan; 106(1):60-4. PubMed ID: 8276209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.